Hannah V Giles (Hannah Giles, H V Giles)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Mass Spectrometry

Multiple Myeloma

High Throughput

Top Venues

Antibodies (Basel, Switzerland)

Blood cancer journal

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Hannah V Giles, Kamaraj Karunanithi
Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies. Antibodies (Basel, Switzerland) 13 (1) (2024)
Hannah V Giles, Kamaraj Karunanithi
Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies. Antibodies (Basel, Switzerland) 13 (1) (2024)
Hannah V Giles, Kamaraj Karunanithi
Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies. Antibodies (Basel, Switzerland) 13 (1) (2024)
Hannah V Giles, Mark T Drayson, B Kishore, Charlotte Pawlyn, Martin F Kaiser, Curly T C M Morris, R de Tute, R G Owen, David A Cairns, T Menzies, F E Davies, G J Morgan, Guy Pratt, G H Jackson
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry. Blood cancer journal 14 (1) (2024)
Hannah V Giles, Mark T Drayson, B Kishore, Charlotte Pawlyn, Martin F Kaiser, Curly T C M Morris, R de Tute, R G Owen, David A Cairns, T Menzies, F E Davies, G J Morgan, Guy Pratt, G H Jackson
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry. Blood cancer journal 14 (1) (2024)
Hannah V Giles, Mark T Drayson, B Kishore, Charlotte Pawlyn, Martin F Kaiser, Curly T C M Morris, R de Tute, R G Owen, David A Cairns, T Menzies, F E Davies, G J Morgan, Guy Pratt, G H Jackson
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry. Blood cancer journal 14 (1) (2024)
Hannah V Giles, Kamaraj Karunanithi
Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies. Antibodies (Basel, Switzerland) 13 (1) (2024)
Hannah V Giles, Mark T Drayson, B Kishore, Charlotte Pawlyn, Martin F Kaiser, Curly T C M Morris, R de Tute, R G Owen, David A Cairns, T Menzies, F E Davies, G J Morgan, Guy Pratt, G H Jackson
Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry. Blood cancer journal 14 (1) (2024)
Hannah V Giles, Ashutosh Wechalekar, Guy Pratt
The potential role of mass spectrometry for the identification and monitoring of patients with plasma cell disorders: Where are we now and which questions remain unanswered? British journal of haematology 198 (4) (2022)
Hannah V Giles, Guy Pratt
Janus kinase 2 (JAK2) inhibitors in the treatment of multiple myeloma: modulating the myeloma immune microenvironment. British journal of haematology 192 (3) (2020)